Efficient, footprint-free human iPSC genome editing by consolidation of Cas9/CRISPR and piggyBac technologies

[1]  G. Church,et al.  Supplementary Materials for Genome-wide inactivation of porcine endogenous retroviruses ( PERVs ) , 2015 .

[2]  David E. Root,et al.  Resources for the design of CRISPR gene editing experiments , 2015, Genome Biology.

[3]  Renyi Liu,et al.  ITIS, a bioinformatics tool for accurate identification of transposon insertion sites using next-generation sequencing data , 2015, BMC Bioinformatics.

[4]  Jonathon T. Hill,et al.  Poly peak parser: Method and software for identification of unknown indels using sanger sequencing of polymerase chain reaction products , 2014, Developmental dynamics : an official publication of the American Association of Anatomists.

[5]  Gang Wang,et al.  Targeted and genome-wide sequencing reveal single nucleotide variations impacting specificity of Cas9 in human stem cells , 2014, Nature Communications.

[6]  I. Lemischka,et al.  Genomic editing tools to model human diseases with isogenic pluripotent stem cells. , 2014, Stem cells and development.

[7]  Kiran Musunuru,et al.  Expanding the genetic editing tool kit: ZFNs, TALENs, and CRISPR-Cas9. , 2014, The Journal of clinical investigation.

[8]  Gang Wang,et al.  Optimization of Genome Engineering Approaches with the CRISPR/Cas9 System , 2014, PloS one.

[9]  Zengrong Zhu,et al.  An iCRISPR platform for rapid, multiplexable, and inducible genome editing in human pluripotent stem cells. , 2014, Cell stem cell.

[10]  Feng Chen,et al.  Targeted gene correction minimally impacts whole-genome mutational load in human-disease-specific induced pluripotent stem cell clones. , 2014, Cell stem cell.

[11]  Chad A. Cowan,et al.  Low incidence of off-target mutations in individual CRISPR-Cas9 and TALEN targeted human stem cell clones detected by whole-genome sequencing. , 2014, Cell stem cell.

[12]  George M. Church,et al.  CRISPR/Cas9‐Directed Genome Editing of Cultured Cells , 2014, Current protocols in molecular biology.

[13]  George A. Truskey,et al.  Modeling the mitochondrial cardiomyopathy of Barth syndrome with iPSC and heart-on-chip technologies , 2014, Nature Medicine.

[14]  Gang Wang,et al.  Modeling the mitochondrial cardiomyopathy of Barth syndrome with iPSC and heart-on-chip technologies , 2014 .

[15]  G. Church,et al.  CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering , 2013, Nature Biotechnology.

[16]  George Church,et al.  Optimization of scarless human stem cell genome editing , 2013, Nucleic acids research.

[17]  J. Keith Joung,et al.  piggyBac transposase tools for genome engineering , 2013, Proceedings of the National Academy of Sciences.

[18]  Chad A. Cowan,et al.  Enhanced efficiency of human pluripotent stem cell genome editing through replacing TALENs with CRISPRs. , 2013, Cell stem cell.

[19]  Feng Zhang,et al.  CRISPR-assisted editing of bacterial genomes , 2013, Nature Biotechnology.

[20]  Le Cong,et al.  Multiplex Genome Engineering Using CRISPR/Cas Systems , 2013, Science.

[21]  G. Daley,et al.  The promise of induced pluripotent stem cells in research and therapy , 2012, Nature.

[22]  Shinya Yamanaka,et al.  Generation and characterization of human induced pluripotent stem cells. , 2009, Current protocols in stem cell biology.

[23]  A. Bookout,et al.  High‐Throughput Real‐Time Quantitative Reverse Transcription PCR , 2005, Current protocols in molecular biology.

[24]  A. Bookout,et al.  High‐Throughput Real‐Time Quantitative Reverse Transcription PCR , 2005 .

[25]  I. Gonzalez.  Barth syndrome: TAZ gene mutations, mRNAs, and evolution , 2005, American journal of medical genetics. Part A.

[26]  E. Maestrini,et al.  A novel X-linked gene, G4.5. is responsible for Barth syndrome , 1996, Nature Genetics.